課題項目：長鏈非編碼RNAAFAP1-AS1通過穩(wěn)定YAP促進鼻咽癌發(fā)生發(fā)展的機制，省部級；Opal/TSA多標記免疫熒光技術檢測三陰乳腺癌組織免疫細胞表達譜及臨床應用，廳局級。論文發(fā)表：LongNoncodingRNAAFAP1-AS1IsaCriticalRegulatorofNasopharyngealCarcinomaTumorigenicity，F(xiàn)rontiersinOncology，2020/11/23，IF：6.244；DoseEscalationinEsophagealCancer，InternationalJournalofRadiationOncologyBiologyPhysics，2017/04/16，IF：5.554；Comparativestudyofcisplatin-baseddefinitiveconcurrentchemoradiotherapywithS-1versuspaclitaxelforunresectablelocallyadvancedesophagealsquamouscellcarcinoma.，Oncotarget，2017/03/14，IF：5.168；Pretreatmentnutritionalriskscoresandperformancestatusareprognosticfactorsinesophagealcancerpatientstreatedwithdefinitivechemoradiotherapy.，Oncotarget，2017/10/19，IF：5.168；Multimodaltreatmentbasedonthyroidectomyimprovessurvivalinpatientswithmetastaticanaplasticthyroidcarcinoma：aSEERanalysisfrom1998to2015，GlandSurgery，2020/09/10，IF：3.0。

擅長乳腺癌、肺癌等常見胸部腫瘤、頭頸部腫瘤的放化療及綜合治療